Opioid Prescription Laws by State (2025)
Opioid prescribing in the United States is governed by a complex patchwork of federal DEA regulations and individual state laws. Since the height of the opioid crisis in the mid- 2010s, most states have enacted strict opioid prescribing limits, mandatory Prescription Drug Monitoring Program (PDMP) checks, and naloxone co-prescribing requirements. This guide summarizes the key regulations you need to know.
Federal Baseline: DEA Schedule II Rules
At the federal level, most opioids (oxycodone, hydrocodone, fentanyl, morphine) are classified as Schedule II controlled substances by the DEA. This means:
- No refills — a new prescription is required each time
- Electronic prescribing for controlled substances (EPCS) increasingly required
- Prescribers must hold a valid DEA registration
- Pharmacies must verify prescriber DEA numbers
- The CDC's 2022 Clinical Practice Guideline recommends the lowest effective dose and duration
Prescription Drug Monitoring Programs (PDMPs)
All 50 states now operate a Prescription Drug Monitoring Program. PDMPs are electronic databases that record every controlled substance prescription dispensed. In most states, prescribers are legally required to check the PDMP before prescribing opioids. PDMP data is increasingly shared between states via interstate data-sharing networks like PMP InterConnect and RxCheck.
PDMPs help identify "doctor shopping" (seeking prescriptions from multiple providers), high-risk patients, and overprescribing patterns. Some states now use AI-assisted PDMP analytics to flag potential misuse before a prescription is filled.
State Opioid Prescribing Laws: Overview Table
The following table summarizes prescribing limits and requirements for selected states. Always verify with your state's medical board for the most current rules.
| State | Initial Day Limit | PDMP Program | Naloxone | Key Notes |
|---|---|---|---|---|
| California | 7 days | CURES (mandatory) | Co-prescribe recommended | Acute pain limit: 7 days |
| Florida | 3 days | E-FORCSE (mandatory) | Required at risk patients | 3-day acute limit, strict enforcement |
| New York | 7 days | ISTOP (mandatory) | Co-prescribe required | Electronic prescribing required |
| Texas | 10 days | PMP AWARxE (mandatory) | Recommended | 10-day acute limit |
| Ohio | 7 days | OARRS (mandatory) | Required at risk patients | Among strictest in US |
| Massachusetts | 7 days | PMP InterConnect (mandatory) | Co-prescribe required | Informed consent required |
| Illinois | 7 days | PMP InterConnect (mandatory) | Recommended | 7-day initial limit |
| Pennsylvania | 7 days | PA PDMP (mandatory) | Co-prescribe recommended | Opioid treatment agreements |
| Georgia | 5 days | PDMP (mandatory) | Recommended | 5-day initial limit |
| Arizona | 5 days | AIMS (mandatory) | Co-prescribe required | Good Samaritan protections |
Naloxone Co-Prescribing Requirements
Naloxone (Narcan) is an opioid overdose reversal medication. An increasing number of states require or strongly recommend that prescribers co-prescribe naloxone when prescribing high-dose opioids or to patients at elevated overdose risk. As of 2025, naloxone is available without a prescription in all 50 states, and many states have enacted standing orders enabling pharmacies to dispense it directly.
Telehealth & Opioid Prescribing
Telehealth opioid prescribing rules have evolved significantly since the COVID-19 pandemic. The DEA has established new rules for telemedicine-based controlled substance prescribing, including requirements for in-person evaluation before prescribing certain opioids. State rules on telehealth prescribing vary; some states have enacted additional restrictions beyond federal minimums.
Patient Rights Under Opioid Laws
While opioid laws aim to reduce misuse, patients with legitimate pain conditions retain important rights. If you are denied medication you believe you need, you have the right to request a second opinion, request documentation of the prescriber's reasoning, and file a complaint with your state medical board if you believe care was withheld inappropriately. Many states also have intractable pain treatment acts that protect patients with chronic pain from being undertreated.